Publikationen
| 1. | Increased Bioavailability of 11-Keto-β-Boswellic Acid Following Single Oral Dose Frankincense Extract Administration After a Standardized Meal in Healthy Male Volunteers: Modeling and Simulation Considerations for Evaluating Drug Exposures. Skarke C, Kuczka K, Tausch L, Werz O, Rossmanith T, Barrett JS, Harder S, Holtmeier W, Schwarz JA
J Clin Pharmacol. 2011 Dec;0(0):0.
|
| 2. | Pharmakokinetische Arzneimittelinteraktionen zwischen Tumortherapeutika und Arzneimitteln der Komplementären Medizin: Mechanismen und klinische Relevanz. Unger M
Forsch Komplementmed. 2011;18(4):213-8.
|
| 3. | Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometry. Gerbeth K, Meins J, Kirste S, Momm F, Schubert-Zsilavecz M, Abdel-Tawab M
J Pharm Biomed Anal. 2011 Dec;56(5):998-1005.
|
| 4. | A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-β-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Bleif S, Hannemann F, Zapp J, Hartmann D, Jauch J, Bernhardt R
Appl Microbiol Biotechnol. 2012 Feb;93(3):1135-46.
|
| 5. | Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Sharma A, Gupta NK, Dixit VK
Drug Deliv. 2010 Nov;17(8):587-95.
|
| 6. | 3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. Goel A, Ahmad FJ, Singh RM, Singh GN
J Pharm Pharmacol. 2010 Feb;62(2):273-8.
|
| 7. | Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Krüger P, Kanzer J, Hummel J, Fricker G, Schubert-Zsilavecz M, Abdel-Tawab M
Eur J Pharm Sci. 2009 Feb;36(2-3):275-84.
|
| 8. | Metabolism of boswellic acids in vitro and in vivo. Krüger P, Daneshfar R, Eckert GP, Klein J, Volmer DA, Bahr U, Müller WE, Karas M, Schubert-Zsilavecz M, Abdel-Tawab M
Drug Metab Dispos. 2008 Jun;36(6):1135-42.
|
| 9. | Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11-keto beta-boswellic acid in human plasma by high-performance thin-layer chromatography. Shah SA, Rathod IS, Suhagia BN, Patel DA, Parmar VK, Shah BK, Vaishnavi VM
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr;848(2):232-8.
|
| 10. | Compression coated systems for colonic delivery of 5-fluorouracil. Sinha VR, Singh A, Singh S, Bhinge JR
J Pharm Pharmacol. 2007 Mar;59(3):359-65.
|
| 11. | Modulation of Pgp function by boswellic acids. Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab M
Planta Med. 2006 May;72(6):507-13.
|
| 12. | Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. Frank A, Unger M
J Chromatogr A. 2006 Apr;1112(1-2):255-62.
|
| 13. | High-performance liquid chromatographic determination of acetyl-11-keto-alpha-boswellic acid, a novel pentacyclic triterpenoid, in plasma using a fluorinated stationary phase and photodiode array detection: application in pharmacokinetic studies. Büchele B, Zugmaier W, Genze F, Simmet T
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec;829(1-2):144-8.
|
| 14. | Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometry. Reising K, Meins J, Bastian B, Eckert G, Mueller WE, Schubert-Zsilavecz M, Abdel-Tawab M
Anal Chem. 2005 Oct;77(20):6640-5.
|
| 15. | Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Sterk V, Büchele B, Simmet T
Planta Med. 2004 Dec;70(12):1155-60.
|
| 16. | Pharmacokinetic study of 11-Keto beta-Boswellic acid. Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R
Phytomedicine. 2004 Feb;11(2-3):255-60.
|
| 17. | Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection. Büchele B, Simmet T
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct;795(2):355-62.
|
| 18. | Determination of 11-keto-boswellic acid in human plasma. Kaunzinger A, Baumeister A, Cuda K, Häring N, Schug B, Blume HH, Raddatz K, Fischer G, Schubert-Zsilavecz M
J Pharm Biomed Anal. 2002 May;28(3-4):729-39.
|
| 19. | Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasma. Tawab MA, Kaunzinger A, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M
J Chromatogr B Biomed Sci Appl. 2001 Sep;761(2):221-7.
|